Ozempic, and its sister drug Wegovy, have the same active ingredient semaglutide ... as a revolutionary way to tackle obesity, which costs the NHS and wider society billions of pounds per year. But ...
Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023. Pipeline ...